Skip to main content
. Author manuscript; available in PMC: 2015 Aug 26.
Published in final edited form as: Hepatol Res. 2011 Aug;41(8):754–762. doi: 10.1111/j.1872-034X.2011.00815.x

Figure 3.

Figure 3

Effect of weight loss on ceramide-related gene expression in the liver. Graphs depict mean ± standard error of the mean of hepatic gene expression at baseline (Pre) and after 1 year of intervention (Post). Comparisons were made between lifestyle (n = 21) vs standard enrichment protocol controls (n = 10). (a) SPTLC1, (b) SPTLC2, (c) CER1, (d) CER2, (e) CER4, (f) SMPD-1, (g) SMPD-3, (h) UGCG. mRNA levels were normalized to 18S rRNA. CER, ceramide synthase; SMPD, sphingomyelin phosphodiesterase; SPTLC, serine palmitoyltransferase; UGCG, uridine diphosphate glucose ceramide glucosyltransferase.